P0506 AZD7798, a monoclonal antibody depleting CCR9+ T cells, with the potential to target hard-to-treat small bowel Crohn’s disease

医学 克罗恩病 单克隆抗体 单克隆 炎症性肠病 疾病 免疫学 抗体 内科学
作者
Nick Powell,Charlotte Hedin,Andrew R. Harper,James Mackay,P. Lundin,David Bock,Enti Spata,G Bouma,S Tian,Anna Lundahl,Jonathan N. Lund,Steven Eck,Agnieszka Popinska,A. Strömbeck,Ann Fowler,Michael Eberhardson,Maria G. Belvisi,Daniel JB Marks
出处
期刊:Journal of Crohn's and Colitis [Oxford University Press]
卷期号:19 (Supplement_1): i1047-i1048
标识
DOI:10.1093/ecco-jcc/jjae190.0680
摘要

Abstract Background Crohn’s disease (CD) can affect any part of the gastrointestinal tract, but about 30% of patients have inflammation restricted to the ileum. In clinical trials, patients are typically enrolled irrespective of the disease localisation, with clinical outcomes focusing on a broad patient population. Anecdotally, small bowel healing in CD is often reported as challenging. Our aims were to investigate the unmet need in treating ileal CD and explore potential drug targets for this patient subpopulation. Methods A systematic review and meta-analysis was conducted of efficacy by disease location (Montreal classification L1 + L2) in placebo-controlled clinical trials in CD. As this revealed markedly different outcomes in ileal compared to colonic CD, transcriptomic data from 1185 small and large intestine biopsies of 594 CD patients were explored to identify potential small bowel specific drug targets, from which the chemokine receptor CCR9 emerged as high interest. AZD7798, a monoclonal antibody designed to deplete CCR9+ T cells, was evaluated in a randomized, placebo-controlled, double-blind first-in-human healthy volunteer study (NCT05452304), and in small bowel Crohn’s patients in a PET imaging study (NCT06053424). Results In the meta-analysis, marked differences were observed in efficacy of existing CD treatments in small compared to large bowel disease (Fig.1). Outcomes across mechanisms of action were not significantly different from placebo in small bowel CD (OR 1. 07, 95% CI 0.64-1.78, p=0.79) yet were superior in colonic CD (OR 3.86, 95% CI 2.75-5.42, p<0.001). Next, transcriptomic analyses identified CCR9 and its ligand CCL25 as highly and selectively expressed in terminal ileum compared to large bowel. Subsequently AZD7798, a CCR9+ T cell depleting antibody, was evaluated in 106 healthy participants in a first-in-human study, and in 6 CD patients in a Phase 1b study. There were no SAEs or treatment discontinuations, and rapid and sustained depletion of CCR9+ T cells in blood was observed in both studies. Moreover, AZD7798 reduced target cells in small bowel in CD patients as detected using a novel CCR9 tracer (Fig.2). Conclusion Ileal CD represents a high unmet need patient subpopulation, where existing treatments appear less effective than for colonic disease. CCR9 is identified as an attractive target for small bowel-dominant inflammation. AZD7798, a first-in-class CCR9+ T cell depleting antibody, demonstrated acceptable safety and tolerability alongside sustained CCR9+ T cell reductions in blood and small intestine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
七颗茶香豆完成签到,获得积分0
刚刚
刚刚
刚刚
酷波er的应助被葫芦侠采纳,获得10
1秒前
1秒前
2秒前
领导范儿的应助被天真苑睐采纳,获得10
2秒前
tianxie完成签到,获得积分10
2秒前
哈哈哈哈完成签到,获得积分10
2秒前
cheng发布了新的文献求助10
2秒前
3秒前
cdercder的应助被caohan采纳,获得10
3秒前
沛林发布了新的文献求助10
3秒前
3秒前
莫非完成签到,获得积分10
4秒前
4秒前
科研通AI65的应助被灵巧绿海采纳,获得10
5秒前
GIN的应助被jjking采纳,获得10
5秒前
xl发布了新的文献求助10
5秒前
自信金鱼发布了新的文献求助30
5秒前
llllllll发布了新的文献求助10
6秒前
yxx完成签到,获得积分10
7秒前
碧蓝大地完成签到,获得积分10
7秒前
7秒前
姐夫开花店完成签到 ,获得积分10
7秒前
玩命做科研完成签到,获得积分10
9秒前
匆匆发布了新的文献求助10
9秒前
leihai发布了新的文献求助10
10秒前
zhaoyiming完成签到,获得积分10
10秒前
左惋庭完成签到,获得积分10
10秒前
隐形的星月完成签到,获得积分10
10秒前
明乎坦涂完成签到,获得积分10
11秒前
11秒前
11秒前
11秒前
xpy0227发布了新的文献求助10
12秒前
GIN的应助被魏同心采纳,获得10
12秒前
Estelle完成签到,获得积分10
12秒前
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193304
求助须知:如何正确求助?哪些是违规求助? 9579440
关于积分的说明 21865699
捐赠科研通 7792811
什么是DOI,文献DOI怎么找? 3437201
关于科研通互助平台的介绍 2560685
邀请新用户注册赠送积分活动 2483996